Terns Pharmaceuticals, Inc. (TERN) Tops Q1 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 set for muted open after big bank earnings, chip slide weighs
- Oil eases as traders monitor Russian diesel deal, Saudi attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
Tweet
Share
E-mailGet Alerts TERN Hot Sheet
Join SI Premium – FREE
Terns Pharmaceuticals, Inc. (NASDAQ: TERN) reported Q1 EPS of ($0.26), $0.04 better than the analyst estimate of ($0.30).
For earnings history and earnings-related data on Terns Pharmaceuticals, Inc. (TERN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Upgrades Telefonica S.A. (VIV) to Neutral
- UBS Reiterates Buy Rating on Accenture plc (ACN) Ahead of Analyst Day
- Nurix (NRIX) PT Lowered to $35 at RBC Capital
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
